Navigation Links
XTENT Announces European Regulatory Update
Date:6/12/2008

MENLO PARK, Calif., June 12 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today announced a progress update regarding its application to the designated European Notified Body for CE Mark approval of its Custom NX(R) DES System. XTENT's European Notified Body confirmed that recently presented six-month follow up results from the CUSTOM III study will be incorporated by the Drug Agency, which reviews the drug formulation submission of XTENT's CE Mark application, into its current review cycle. XTENT's CE Mark application, which included two components, the XTENT design dossier and the drug formulation submission, was filed in December 2007.

"Given the positive results of CUSTOM III, we are encouraged that the Drug Agency, which has already approved Biolimus A9(R) and PLA combinations on two other DES platforms, has accepted the additional data for review. This, we believe strengthens an already robust submission for our Custom NX System," said Gregory D. Casciaro, XTENT's President and CEO. The company anticipates a response from its European Notified Body regarding its CE Mark application this summer.

About the Custom NX(R) DES System

Custom NX is designed to enable a more personalized approach to the treatment of arterial disease based on each patient's individual lesion characteristics. The Custom NX system allows physicians to customize the length and diameter of the stent at the site of the lesion. The system features a proprietary modular stent design that consists of multiple 6 mm cobalt chromium segments coated with Biolimus A9(R) and PLA, a biodegradable drug carrier. The Custom NX delivery system enables the stent length to be adjusted in 6mm increments and allows for the placement of up to 60mm of sten
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
2. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
3. XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
4. XTENT Announces First Quarter 2008 Financial Results
5. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
6. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
7. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
10. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
11. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
(Date:5/23/2013)... N.M. , May 23, 2013  Net Medical ... the telemedicine market, announced today the company has signed ... telemedicine staffing company based in Huntsville, AL ... that specializes in the staffing and recruitment of telemedicine ... completion of the final agreement, which is expected by ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing 2Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing 3Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 2Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 3Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 4Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 5Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 6Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 7Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 8Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 9Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 10Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 11Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 12Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 13Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 14Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 15Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 16Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 17Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results 18
(Date:5/25/2013)... 2013 Ayurveda is the traditional ... of life". While a medical science, its scope enters into ... Its fundamental philosophy is that disease is the end result ... to re-establish optimal health, one must discover where we are ... which brings us back into perfect harmony. , The Foundations ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html ... of a judge's overturning of a jury's award of ... the first trial* in the country over allegations that ... to court files. , The judge in the case ... to show his cancer was caused by the medication.** ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... in March, 2013. Taylor Swift fans can add code RED ... album with wild sales, setting a record 1.2 million sales during ... spent five weeks at the top of the Billboard Album charts, ... Red Concert Tour, album sales are expected to continue at ...
(Date:5/24/2013)... Range Kleen Mfg. strives to “TCOTC.” Our number one motto ... desk to the Shipping Dock.” We hold high in our ... while creating excellence and quality being results oriented. It is ... right thing and what better way to help with a ... Throughout the year Range Kleen donates to numerous local charities ...
(Date:5/24/2013)... By Alan Mozes HealthDay Reporter , , FRIDAY, ... Stacy Lewis, accomplishments are remarkable. But it was a ... to the top of her sport. "I was ... golf when my scoliosis was diagnosed by my orthopedic ... both the Scoliosis Research Society and the American Academy ...
Breaking Medicine News(10 mins):Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:Taylor Swift Tickets: Cheap Concert Tickets has Slashed Prices on Taylor Swift Concert Tickets in Arlington/Dallas, Philadelphia, East Rutherford, Los Angeles & Tacoma 2Health News:Taylor Swift Tickets: Cheap Concert Tickets has Slashed Prices on Taylor Swift Concert Tickets in Arlington/Dallas, Philadelphia, East Rutherford, Los Angeles & Tacoma 3Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3
... Feb. 6 Baycap Inc. ("Baycap"),today announced that it ... School. Todd Coordt and Peter Metropoulos, directors at Baycap,are ... commented:,"This provides the school with top of the line ... The equipment will allow Mira Costa to add ...
... Union asks board member to seek restatement of Beth ... Staples director Martin Trust,should apply the same Sarbanes-Oxley standards ... role on the board of Beth Israel Deaconess,Medical Center ... East. Trust is the CEO of Samtex and a ...
... America,s favorite doctor,Mehmet Oz, M.D., recently revealed ... Winfrey Show with blueberries topping the list as ... one of his,"favorite" anti-aging superfoods. "You can tell ... color. All foods with dark colors in,them have ...
... Mangrove Employer Services, a,leading software and services ... and Self Service solutions,announces the launch of its ... Services teamed up with an experienced and trusted,partner, ... services, in 2007 to provide this new offering. ...
... seek restatement of Beth Israel Deaconess,Medical Center audit, ... the same Sarbanes-Oxley standards used by Staples and other,publicly ... Beth Israel Deaconess,Medical Center (BIDMC), according to labor group ... directors should,take similar action, says a letter sent today ...
... Feb. 6 HLTH,Corporation (Nasdaq: HLTH ) and ... ), today announced that they will release their respective,financial ... at,approximately 4:00 pm (ET) on Thursday, February 21, 2008. ... (ET) on that day to discuss those,results., Investors ...
Cached Medicine News:Health News:Staples Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Dr. Oz and Oprah Pick Antioxidant-Rich Blueberries for Ultimate Checklist for Great Aging 2Health News:Mangrove Announces Health Savings Account (HSA) and Health Reimbursement Account (HRA) Product Launches 2Health News:Board Members of Five Massachusetts Companies Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call 2
Reliable and Affordable. The Schuco 3000 Nebulizer by Allied has been designed to offer a compact style that provides worry-free affordable nebulizer therapy....
... Graham-Field has been developing ... than 58 years. Our medical-surgical ... reputation for innovation, quality and ... brands include the Labtron® line ...
... of medication as well as humidification, try ... dilution, high volume, continuous medication nebulizer (CMN), ... patients. Its 200 ml reservoir and jet ... hours of nebulized medication delivery at 25 ...
Rotary Piston Nebulizer...
Medicine Products: